4//SEC Filing
Gros David-Alexandre C 4
Accession 0001209191-23-026732
CIK 0001404281other
Filed
May 1, 8:00 PM ET
Accepted
May 2, 6:49 PM ET
Size
5.7 KB
Accession
0001209191-23-026732
Insider Transaction Report
Form 4
Gros David-Alexandre C
DirectorChief Executive Officer
Transactions
- Award
Common Stock (right to buy)
2023-05-01+383,299→ 383,299 totalExercise: $2.30Exp: 2033-05-01→ Common Stock (383,299 underlying)
Footnotes (1)
- [F1]This option represents a right to purchase up to 383,299 shares of Common Stock, which option vests with respect to 95,825 shares on May 1, 2024, and then with respect to 6.25% of the underlying shares quarterly over the three-year period ending May 1, 2027.
Documents
Issuer
Eledon Pharmaceuticals, Inc.
CIK 0001404281
Entity typeother
Related Parties
1- filerCIK 0001644489
Filing Metadata
- Form type
- 4
- Filed
- May 1, 8:00 PM ET
- Accepted
- May 2, 6:49 PM ET
- Size
- 5.7 KB